H. Schouten

发表

The role of stem cell transplantation in the management of relapsed follicular lymphoma in the era of targeted therapies

P. Dreger, J. Norman, H. Schouten, 2018, Bone Marrow Transplantation.

High-dose daunorubicin in older patients with acute myeloid leukemia.

H. Döhner, P. Sonneveld, E. Vellenga, 2009, The New England journal of medicine.

Adjuvant chemohormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive breast cancer patients.

J. Jager, L. Schouten, J. D. de Jong, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Cytarabine dose for acute myeloid leukemia.

Augustin Ferrant, Bob Löwenberg, Alois Gratwohl, 2011, The New England journal of medicine.

Clinical Cancer Research Collaborative Group (SAKK) and for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), and Swiss Group for

E. Vellenga, M. Fey, A. Gratwohl, 2011 .

Autologous peripheral blood stem cell transplantation for acute myeloid leukemia.

E. Vellenga, M. Fey, A. Gratwohl, 2011, Blood.

The first study published?

F. Erdkamp, P. M. van der Kuy, H. Schouten, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.

R. Brand, G. Ossenkoppele, J. Cornelissen, 2005, Haematologica.

Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.

R. Brand, G. Ossenkoppele, J. Cornelissen, 2005, Haematologica.

DNA aneuploidy in Hodgkin's disease: a multiparameter flow cytometric analysis.

J. Hoffmann, F. Erdkamp, G. Blijham, 1994, Leukemia & lymphoma.

Invasive aspergillosis in immunocompromised patients: findings on plain film and (HR)CT.

J. V. van Engelshoven, F. Thunnissen, H. Schouten, 1992, European journal of radiology.

Prevalence of pain in patients with cancer: a systematic review of the past 40 years.

H C Schouten, M. van Kleef, A. Kessels, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Course of Fatigue Between Two Cycles of Adjuvant Chemotherapy in Breast Cancer Patients

A. Courtens, H. Abu‐Saad, A. Kester, 2006, Cancer nursing.

Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants.

M. Norkin, H. Nakasone, M. Aljurf, 2018, Blood advances.

Providing personalized prognostic information for adult leukemia survivors.

Alan M. Miller, B. Storer, B. George, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease.

J. Klein, M. Horowitz, J. Wingard, 2011, Blood.

Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.

J. V. Stone, J. Klein, J. Wingard, 1999, The New England journal of medicine.

Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT

M. Labopin, D. Blaise, A. Nagler, 2018, Journal of Hematology & Oncology.

Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma.

J. Fay, W. Wood, J. Maciejewski, 2018, Leukemia research.

Associations between gender , disease features and symptom burden in the MPN population : An analysis by the MPN QOL International Working Group

K. Döhner, M. Griesshammer, T. Barbui, 2016 .

Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs.

K. Döhner, M. Griesshammer, T. Barbui, 2017, Leukemia research.

Symptom Burden Profile in Myelofibrosis Patients with Thrombocytopenia: Lessons and Unmet Needs

K. Döhner, M. Griesshammer, T. Barbui, 2015 .

Treatment options for myelofibrosis and myeloproliferative neoplasia

H. Schouten, S. Koopmans, S. M. Koopmans, 2013 .

A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Myelodysplastic Syndromes Patients.

R. Vij, W. Wood, M. Aljurf, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

H. Einsele, G. Dini, A. Velardi, 2010, Bone Marrow Transplantation.

Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial

A. Hagemeijer, R. Willemze, A. Gratwohl, 2010, Haematologica.

Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.

M. Kersten, D. de Jong, O. Hoekstra, 2019, Haematologica.

The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT

H. Einsele, D. Niederwieser, W. Rabitsch, 2009, Bone Marrow Transplantation.

ALTERNATIVE DONORS EXTEND TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA WHO LACK AN HLA MATCHED DONOR

S. Montoto, Sonali M. Smith, D. Maloney, 2014, Bone Marrow Transplantation.

The role of mini-allotransplants in the treatment of solid tumors.

H. Schouten, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation.

D. Weisenburger, J. Armitage, P. Bierman, 1989, Blood.

Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes.

M. Norkin, W. Wood, M. Sorror, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

J. Vose, Sonali M. Smith, P. Hari, 2012, Blood.

Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study.

S. Montoto, P. Chevallier, D. Blaise, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rituximab‐PECC induction followed by 90Y‐ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study

M. Kersten, D. de Jong, J. Zijlstra, 2019, British journal of haematology.

Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure

J. Vose, Sonali M. Smith, R. Vij, 2018, Cancer.

Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma.

S. Montoto, P. Hari, D. Maloney, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

lymphoma: myeloablative or reduced intensity? Conditioning regimens for allotransplants for diffuse large B-cell

Sonali M. Smith, P. Hari, P. Armand, 2012 .

Murine dendritic cells that are resistant to maturation are unable to induce tolerance to allogeneic stem cells.

G. Bos, H. Schouten, A. Vanclée, 2006, Transplant immunology.

Elimination of the chemotherapy resistant subpopulation of 4T1 mouse breast cancer by haploidentical NK cells cures the vast majority of mice

G. Bos, L. Wieten, H. Schouten, 2011, Breast Cancer Research and Treatment.

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.

R. Gale, H. Khoury, U. Popat, 2018, Blood advances.

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study.

N. Aaronson, M. Muller, E. Wouters, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concentrated citrate locking in order to reduce the long-term complications of central venous catheters: a randomized controlled trial in patients with hematological malignancies

K. Hamulýak, K. Jie, A. Verbon, 2014, Supportive Care in Cancer.

Congenital Thrombophilia and Central Venous Catheter-Related Thrombosis in Patients With Cancer

K. Hamulýak, H. Cate, H. Schouten, 2010, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Clinical guide to fertility preservation in hematopoietic cell transplant recipients

M. Sorror, J. Wingard, J. Pidala, 2014, Bone Marrow Transplantation.

Treatment and relative survival in very elderly patients with DLBCL in The Netherlands: a population-based study, 1989 to 2015.

O. Visser, D. Issa, P. Lugtenburg, 2017, Blood advances.

Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK).

E. Vellenga, M. Jongen‐Lavrencic, J. Passweg, 2012, Blood.

Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure

S. Verstovsek, R. Mesa, M. Talpaz, 2020, American journal of hematology.

Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group.

P. Sonneveld, G. Ossenkoppele, W. van Putten, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.

J. Vose, J. Winter, P. Hari, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).

M. Sorror, J. Wingard, M. Gilleece, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates

F. Erdkamp, H. Schouten, M. Fickers, 2001, Annals of Hematology.

Chromosomal abnormalities in Hodgkin's disease are not restricted to Hodgkin/Reed–Sternberg cells

J. Arends, F. Ramaekers, A. Hopman, 1998, The Journal of pathology.

Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.

P. Sonneveld, B. van der Holt, H. Kluin-Nelemans, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Invasive aspergillosis in immunocompromised (HR)CT patients: findings on plain film and

F. Thunnissen, H. Schouten, 1992 .

Cell turnover parameters in small and large cell varieties of primary intestinal non‐hodgkin's lymphoma

J. Arends, H. Schouten, F. Bot, 1998, Cancer.

Current situation for medication process and pharmacovigilance in The Netherlands: a comparison between cytostatic and non-cytostatic agents

B. Winkens, R. Janknegt, P. M. van der Kuy, 2013 .

Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M. Mohty, P. Moreau, J. S. San Miguel, 2013, Annals of Oncology.

Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults.

P. Sonneveld, E. van den Berg, B. van der Holt, 2004, Leukemia research.

Proliferation and apoptosis in primary gastric B‐cell non‐Hodgkin's lymphoma

J. Arends, H. Schouten, H. Schouten, 1997, Histopathology.

Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experiment.

A. Falanga, H. ten Cate, A. T. ten Cate‐Hoek, 2020, European journal of internal medicine.

Features of a new full length HLA allele: A*02:455.

M. Tilanus, M. Groeneweg, H. Schouten, 2015, Tissue antigens.

The full length genomic sequence of a novel HLA-C*03 allele: HLA-C*03:219.

M. Tilanus, H. Schouten, C. Voorter, 2015, Tissue antigens.

HSOA Journal of Clinical Immunology and Immunotherapy Alloreactive Natural Killer cells have anti-tumor capacity against disseminated human multiple myeloma in Rag2-/- γ C-/-mice when combined with low dose cyclophosphamide and total body irradiation

M. Tilanus, L. Bloois, R. Groen, 2017 .

Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.

S. Montoto, Sonali M. Smith, P. Hari, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study.

Z. Shun, R. Mesa, M. Talpaz, 2017, The Lancet. Haematology.

Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.

M. Griesshammer, T. Barbui, A. Dueck, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.

Alan M. Miller, M. Norkin, P. Hari, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of transplantation for myelofibrosis.

N. Kröger, M. Horowitz, R. Gale, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

older age : a randomized phase 2 trial of the Dutch-Belgian Cooperative Addition of bevacizumab to chemotherapy in acute myeloid leukemia

E. Vellenga, K. Montfort, M. Jongen‐Lavrencic, 2012 .

Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis

J. Bourhis, N. Kröger, C. Craddock, 2019, Haematologica.

Fibrinolysis in patients with chemotherapy‐induced thrombocytopenia and the effect of platelet transfusion

Y. Henskens, H. Schouten, P. Verhezen, 2019, Journal of thrombosis and haemostasis : JTH.

Biomarkers for Prediction of Central Venous Catheter Related-Thrombosis in Patients With Hematological Malignancies

R. van Oerle, K. Hamulýak, A. T. ten Cate‐Hoek, 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Myelodysplasia presenting with pulmonary manifestations associated with neutrophilic dermatosis

E. V. van Pampus, M. Drent, H. Schouten, 1998, Annals of Hematology.

Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.

J. Vose, M. Aljurf, R. Gale, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation

A. Krishnan, W. Wood, P. Hari, 2015, Bone Marrow Transplantation.

Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma.

A. Krishnan, S. Lonial, R. Vij, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study.

J. Baars, P. Sonneveld, E. Vellenga, 2002, Blood.

Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study

W. J. Mulder, E. Maartense, H. Schouten, 2015, Annals of Hematology.

HLA-matched allo-SCT after reduced intensity conditioning with fludarabine/CY in patients with metastatic breast cancer

G. Bos, H. Schouten, M. V. Gelder, 2010, Bone Marrow Transplantation.

Neutropenia management.

H. Schouten, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ ALLG NHL 24 randomised controlled trial.

M. J. van den Bent, M. Taphoorn, H. Achterberg, 2021, Neuro-oncology.

Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high‐dose methotrexate, and R‐DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study

M. Kersten, J. Baars, P. Lugtenburg, 2017, Hematological oncology.

Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party

J. Finke, D. Blaise, A. Nagler, 2016, Bone Marrow Transplantation.

P53 as a marker of the malignant cell in Hodgkin's disease.

F. Erdkamp, L. Vrints, H. Schouten, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.

M. Norkin, W. Wood, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Value of allogeneic stem cell transplantation (SCT) versus autologous SCT and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial

A. Hagemeijer, R. Willemze, A. Gratwohl, 2010 .

Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT).

W. Stevens, M. Pfreundschuh, C. Sebban, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry.

A. Nagler, G. Ossenkoppele, M. Boogaerts, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP

A. Ganser, J. Bourhis, S. Iacobelli, 2022, Bone Marrow Transplantation.

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

B. Sandmaier, M. Aljurf, R. Gale, 2016, Cancer.

Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma

Sonali M. Smith, N. Kröger, P. Hari, 2015, Bone Marrow Transplantation.

Recombinant human erythropoietin in patients with myelodysplastic syndromes.

E. Vellenga, G. Blijham, H. Schouten, 1991, Leukemia.

What is the role of stem-cell transplantation for follicular non-hodgkin lymphoma in the rituximab era?

H. Schouten, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.

H. Einsele, D. Niederwieser, W. Rabitsch, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial.

M. Sydes, S. Kvaløy, H. Johnsen, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Changes in body weight and serum liver tests associated with parenteral nutrition compared with no parenteral nutrition in patients with acute myeloid leukemia during remission induction treatment

J. Dieleman, S. Beijer, L. Tick, 2020, Supportive Care in Cancer.

Counterflow centrifugation apheresis for the collection of autologous peripheral blood stem cells from patients with malignancies: A comparison with a standard centrifugation apheresis procedure

D. Weisenburger, J. Armitage, R. Wigton, 1990, Journal of clinical apheresis.

Interferon treatment of refractory idiopathic thrombocytopenic purpura (ITP)

H. Hillen, H. Schouten, P. Dubbeld, 1994, European journal of haematology.

The CUP trial: a randomized study analyzing the efficacy of high dose therapy and purging in low-grade non-Hodgkin's lymphoma (NHL).

P. Fayers, M. Sydes, S. Kvaløy, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

High-dose therapy followed by bone marrow transplantation for relapsed follicular non-hodgkin's lymphoma

J. Kluin-Nelemans, M. V. van't Veer, H. Schouten, 1996, Annals of Hematology.

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.

A. Zander, J. Szer, M. Horowitz, 2008, Blood.

Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.

S. Montoto, Sonali M. Smith, P. Hari, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long term disease control. An analysis from the Lymphoma Working Party Of the EBMT.

S. Montoto, A. Ganser, I. Yakoub-Agha, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

An EBMT Prospective Non-Interventional Study of Outcomes and Toxicity of Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Patients Previously Treated with Second Generation Tyrosine Kinase Inhibitors

A. Ganser, N. Kröger, S. Iacobelli, 2016 .

Abnormalities involving chromosome 6 in newly diagnosed patients with non-Hodgkin's lymphoma. Nebraska Lymphoma Study Group.

D. Weisenburger, J. Armitage, W. Sanger, 1990, Cancer genetics and cytogenetics.

Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomas

P. Dreger, A. Shimoni, A. Sureda, 2017, Journal of clinical apheresis.

Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation

M. Kattan, N. Kröger, A. Nagler, 2014, Bone Marrow Transplantation.

Large‐cell anaplastic non‐Hodgkin's lymphoma originating in donor cells after allogenic bone marrow transplantation

J. Arends, A. Hopman, H. Schouten, 1995, British journal of haematology.

Normal hospital and low-bacterial diet in patients with cytopenia after intensive chemotherapy for hematological malignancy: a study of safety.

F. V. van Tiel, A. Kessels, P. Terporten, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Daily challenges in oncology practice

F. Roila, A. Kakkar, O. Ozyılkan, 2006 .

Morphologically normal, CD30‐negative B‐lymphocytes with chromosome aberrations in classical Hodgkin's disease: the progenitor cell of the malignant clone?

J. Arends, M. Stevens-Kroef, A. Hopman, 1999, The Journal of pathology.

Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life: Results in Dutch Patients and Review of the Literature.

R. Raymakers, H. Koene, S. Zweegman, 2019, Clinical lymphoma, myeloma & leukemia.

Partially T-cell-depleted allogeneic stem-cell transplantation for first-line treatment of multiple myeloma: a prospective evaluation of patients treated in the phase III study HOVON 24 MM.

P. Sonneveld, B. van der Holt, M. V. van Oers, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival.

Alan M. Miller, R. Vij, M. Aljurf, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chromosomal abnormalities in patients with non-cutaneous T-cell non-Hodgkin's lymphoma. The Nebraska Lymphoma Study Group.

D. Weisenburger, J. Armitage, W. Sanger, 1990, European journal of cancer.

Viridans streptococci isolated from the bloodstream. Relevance of species identification.

P. Soeters, E. Stobberingh, J. Jacobs, 1995, Diagnostic microbiology and infectious disease.

In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?

C. Craddock, M. Labopin, P. Chevallier, 2015, Bone Marrow Transplantation.

Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research.

P. Hari, R. Gale, M. Cairo, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Keratinocyte growth factor ameliorates acute graft-versus-host disease in a novel nonmyeloablative haploidentical transplantation model

N. Deutz, M. Gijbels, G. Bos, 2005, Bone Marrow Transplantation.

Home treatment for intensive hematological therapies: who will benefit?

H. Schouten, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Specific detection of Helicobactor pylori and non-Helicobactor pylori flora in small-and large-cell primary gastric B-cell non-Hodgkin's lymphoma

J. Arends, D. Jonkers, L. Vrints, 1997 .

Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation—a retrospective study by the Acute Leukemia Working Party of EBMT

M. Labopin, A. Nagler, M. Mohty, 2020, Bone Marrow Transplantation.

Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON

R. Willemze, B. Biemond, J. Cornelissen, 2012, Leukemia.

Double modulation of high-dose 5-fluorouracil with low-dose PALA and methotrexate: results of a randomized EORTC study

G. Blijham, H. Schouten, D. Wagener, 1997 .

Screening for platelet function disorders with Multiplate and platelet function analyzer

H. ten Cate, P. Nelemans, Y. Henskens, 2019, Platelets.

The use of thalidomide in chronic refractory graft versus host disease.

M. V. D. van de Poel, H. Schouten, P. Pasman, 2001, The Netherlands journal of medicine.

Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation.

M. Norkin, M. Aljurf, J. Wingard, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

analysis benefits for whom? results of a HOVON/SAKK donor versus no donor remission acute myeloid leukemia in young and middle aged adults: Myeloablative HLA-identical sibling stem cell transplantation in first

M. Fey, A. Gratwohl, B. Löwenberg, 2013 .

High prevalence of pain in patients with cancer in a large population-based study in The Netherlands

A. Kessels, J. Patijn, M. Kleef, 2007, PAIN.

Non-myeloablative allogeneic stem cell transplantation: a new treatment option for acquired angioedema?

I. Zegers, H. Schouten, C. Nieuwhof, 2015, Netherlands Journal of Medicine.

Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.

Augustin Ferrant, Bob Löwenberg, Alois Gratwohl, 2003, The New England journal of medicine.

The diagnostic accuracy of bleeding assessment tools for the identification of patients with mild bleeding disorders: A systematic review

P. Nelemans, Y. Henskens, S. Schols, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Predictors of lost to follow-up among pediatric and adult hematopoietic cell transplant survivors: A report from the Center for International Blood and Marrow Transplant Research.

W. Wood, M. Aljurf, A. Yoshimi, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

J. V. Stone, J. Klein, J. Wingard, 1999 .

Graft-Versus-Leukemia Effect of Allogeneic Stem-Cell Transplantation and Minimal Residual Disease in Patients With Acute Myeloid Leukemia in First Complete Remission.

V. V. D. van der Velden, M. Jongen‐Lavrencic, M. Vekemans, 2017, JCO precision oncology.

Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study.

H. Döhner, P. Sonneveld, E. Vellenga, 2010, Blood.

Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine.

Bob Löwenberg, Jakob Passweg, Carlos Graux, 2012, Blood.

Fatal infection due to Alcaligenes xylosoxidans subsp. xylosoxidans in a neutropenic host

E. Stobberingh, J. Jacobs, H. Schouten, 1992 .

Multidrug resistance mediated by P-glycoprotein in haematological malignancies.

H. Schouten, P. Pasman, 1993, The Netherlands journal of medicine.

Spinal epidural abscess due to Aspergillus infection of the vertebrae: report of 3 cases.

R. V. van Oostenbrugge, H. Schouten, P. Dubbeld, 1996, The Netherlands journal of medicine.

Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenia.

F. V. van Tiel, A. Kessels, F. Tiel, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease.

K. Döhner, M. Griesshammer, T. Barbui, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Myeloproliferative (MPN) Symptom Burden Response Thresholds: Assessment Of MPN-SAF TSS Quartiles As Potential Markers Of Symptom Response

M. Griesshammer, T. Barbui, A. Dueck, 2013 .

Quality of life and non-pain symptoms in patients with cancer.

M. van Kleef, A. Kessels, J. M. de Rijke, 2009, Journal of pain and symptom management.

Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning.

M. Sorror, J. Wingard, U. Popat, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

N. Schmitz, H. Einsele, G. Dini, 2002, Bone Marrow Transplantation.

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

J. Klein, M. Horowitz, J. Wingard, 2014, Clinical Cancer Research.

Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study

M. van Kleef, J. M. de Rijke, M. Peters, 2008, Psycho-oncology.

Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.

Alan M. Miller, R. Vij, F. Baron, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning.

J. Vose, P. Hari, R. Gale, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes.

R. Brand, D. Niederwieser, F. Locatelli, 2002, Blood.

Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison.

J. Baars, P. Sonneveld, B. van der Holt, 2009, Blood.

Caphosol in prevention of oral mucositis in autologous stem cell transplant recipients after high-dose melphalan (CASH)

O. Visser, K. Theunissen, J. Maertens, 2012 .

Palpitations And Arrhythmia In 3649 High-Risk Patients With Essential Thrombocythemia : Results From The Prospective Long-Term Observational Exels Study

T. Barbui, A. Dueck, R. Mesa, 2016 .

SECOND TRANSPLANTS FOR MULTIPLE MYELOMA RELAPSING AFTER A PRIOR AUTOTRANSPLANT – REDUCED INTENSITY ALLOGENEIC VERSUS AUTOLOGOUS TRANSPLANTATION

A. Krishnan, S. Lonial, P. Hari, 2013, Bone Marrow Transplantation.

Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experience

M. Kersten, H. Lokhorst, M. Minnema, 2011, Bone Marrow Transplantation.

High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study

W. M. Smit, B. van der Holt, G. Verhoef, 2006, Annals of Hematology.

treatment outcome. The Nebraska Lymphoma Study Group lymphoma: associations with histology, clinical characteristics, and Chromosomal abnormalities in untreated patients with non-Hodgkin's

D. Weisenburger, J. Armitage, James R. Anderson, 2011 .

The reliability and value of determining mediastinal involvement and width on chest radiographs in patients with Hodgkin's disease.

F. Erdkamp, G. Blijham, H. Schouten, 1993, European journal of radiology.

Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome. The Nebraska Lymphoma Study Group.

D. Weisenburger, J. Armitage, James R. Anderson, 1990, Blood.

Acute lymphoblastic leukaemia in adults: Immunological subtypes and clinical features at presentation

G. Ossenkoppele, B. Löwenberg, J. Kluin-Nelemans, 1993, Annals of Hematology.

Chromosomal abnormalities in malignant lymphoma and Hodgkin's disease.

J. Armitage, W. Sanger, H. Schouten, 1991, Leukemia & lymphoma.

Acute lymphoblastic leukaemia in pregnancy.

H. Schouten, A. Vos, J. Molkenboer, 2005, The Netherlands journal of medicine.

Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen

F. Baron, M. Labopin, D. Blaise, 2018, Clinical Cancer Research.

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.

Alan M. Miller, P. D. Dal Cin, J. Sierra, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies.

M. Höglund, B. van der Holt, B. Löwenberg, 2003, Experimental hematology.

Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer.

F. Erdkamp, P. Hupperets, G. Blijham, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

BCR-ABL negative myeloproliferative neoplasia: a review of involved molecular mechanisms.

H. Schouten, S. Koopmans, A. V. van Marion, 2015, Histology and histopathology.

Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma

P. Sonneveld, H. Kluin-Nelemans, P. Kluin, 2005, Leukemia.

Incomplete chimerism in erythroid, myeloid and B lymphocyte lineage after T cell-depleted allogeneic bone marrow transplantation.

A. Hagenbeek, B. Löwenberg, H. Schouten, 1988, Bone marrow transplantation.

Older patients with myeloma derive similar benefit from autologous transplantation.

A. Krishnan, S. Lonial, P. Hari, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.

R. Vij, M. Aljurf, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Advantages and limitations of (non-)myeloablative allogeneic stem cell transplantation.

D. Huugen, G. Bos, H. Schouten, 2002, The Netherlands journal of medicine.

Haploidentical stem cell transplantation for patients with lymphoma: a position statement from the Lymphoma Working Party-European Society for Blood and Marrow Transplantation

N. Schmitz, S. Montoto, S. Dietrich, 2019, Bone Marrow Transplantation.

Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation

J. Finke, P. Dreger, S. Choquet, 2016, Leukemia.

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.

W. Wood, M. Sorror, F. Baron, 2017, Blood.

A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma.

Alan M. Miller, J. Armitage, J. Vose, 2003, Blood.

Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group

K. Döhner, M. Griesshammer, T. Barbui, 2016, Haematologica.

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

Ruta Bajorunaite, Arturo Molina, John Gibson, 2003, Blood.

Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure.

Alan M. Miller, J. Vose, Sonali M. Smith, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term Survival and Late Effects among 1-year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

Zhiwei, Saber, M. Norkin, 2014 .

Temporal relationship between HHV 6 and graft vs host disease in a patient after haplo-identical SCT and severe T-cell depletion

H. Schouten, M. V. Gelder, A. V. Brands-Nijenhuis, 2011, Bone Marrow Transplantation.

Graft-versus-tumor effects on murine mammary carcinoma in a model of nonmyeloablative haploidentical stem cell transplantation

G. Bos, H. Schouten, M. Gelder, 2006, Bone Marrow Transplantation.

Salvage second hematopoietic cell transplantation in myeloma.

J. Vose, A. Krishnan, S. Lonial, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of acute and chronic graft-versus-host disease on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma

S. Lonial, P. Hari, A. Dispenzieri, 2011, Bone Marrow Transplantation.

Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.

R. Vij, M. Aljurf, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

M. Norkin, W. Wood, J. Snowden, 2016, Bone Marrow Transplantation.

American Journal of Epidemiology Original Contribution Body Mass Index, Height, and Risk of Lymphatic Malignancies: a Prospective Cohort Study

R. Goldbohm, L. Schouten, R. Pylypchuk, 2022 .

Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy.

A. Courtens, H. Abu‐Saad, M. Candel, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Managing Anti-Platelet Therapy in Thrombocytopaenic Patients with Haematological Malignancy: A Multinational Clinical Vignette-Based Experiment

D. Pereg, A. Falanga, H. ten Cate, 2018, Thrombosis and Haemostasis.

Study ofStomatococcus mucilaginosus isolated in a hospital ward using phenotypic characterization

J. Jacobs, F. Tiel, B. Slangen, 1995, European Journal of Clinical Microbiology and Infectious Diseases.

DNA aneuploidy and cell proliferation in relation to histology and prognosis in patients with Hodgkin's disease.

J. Hoffmann, F. Erdkamp, J. Wijnen, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry.

P. Pedrazzoli, D. Blaise, F. Lanza, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands.

J. Jager, L. Schouten, J. M. de Rijke, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.

W. Stevens, D. de Jong, J. Baars, 2019, The Lancet. Oncology.

Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party

E. Kimby, G. Salles, A. López-Guillermo, 2013, Haematologica.

Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML.

E. Vellenga, M. Jongen‐Lavrencic, J. Passweg, 2017, Blood.

Myeloproliferative neoplasia: a review of clinical criteria and treatment.

H. Schouten, S. Koopmans, A. V. van Marion, 2012, The Netherlands journal of medicine.

Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.

M. Norkin, M. Boeckh, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.

J. Klein, M. Horowitz, J. Wingard, 2011, Blood.

Inappropriate costimulation and aberrant DNA methylation as therapeutic targets in angioimmunoblastic T-cell lymphoma

H. Schouten, M. Willemsen, 2017, Biomarker Research.

Anti-Apoptotic Pathways in Bone Marrow and Megakaryocytes in Myeloproliferative Neoplasia

H. Schouten, S. Koopmans, A. V. van Marion, 2013, Pathobiology.

Fatigue in Patients With Breast Cancer Receiving Adjuvant Chemotherapy: A Review of the Literature

Nynke de Jong, A. Courtens, H. Abu‐Saad, 2002, Cancer nursing.

"Downhill" oesophagus varices: a clue to a serious disease.

H. Schouten, C. Van Deursen, A. Saleh, 1992, The Netherlands journal of medicine.

Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.

J. Cortes, M. Aljurf, J. Szer, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.

J. Cortes, M. Aljurf, J. Szer, 2013, Blood.

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report

J. Mehta, M. Perales, N. Saba, 2019, Clinical Cancer Research.

Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer

J. Nortier, E. Voest, F. Erdkamp, 2000, British Journal of Cancer.

Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: The European Bone Marrow Transplant Group experience

P. Colombat, N. Gorin, A. Goldstone, 1994 .

Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: the European Bone Marrow Transplant Group experience. EBMT Working Party for Lymphoma.

P. Colombat, N. Gorin, A. Goldstone, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation.

J. Vose, S. Montoto, Sonali M. Smith, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation.

D. Weisenburger, J. Armitage, L. Klassen, 1989, Bone marrow transplantation.

Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT

J. Esteve, M. Labopin, A. Nagler, 2016, Haematologica.

with TBI following cyclophosphamide in combination with busulfan compared Better leukemia-free and overall survival in AML in first remission

J. Cortes, M. Aljurf, J. Szer, 2013 .

Diagnosis, staging and prognostic factors.

H. Schouten, 2007, Annals of Oncology.

Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR

S. Montoto, Sonali M. Smith, M. Pasquini, 2018, Cancer.

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen.

S. Montoto, Sonali M. Smith, J. Klein, 2015, Biology of Blood and Marrow Transplantation.

Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.

J. Vose, Sonali M. Smith, P. Hari, 2008, Biology of Blood and Marrow Transplantation.

Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission

J. Esteve, M. Labopin, P. Chevallier, 2018, American journal of hematology.

Expression of CD10, CD75 and CD43 in MALT lymphoma and their usefulness in discriminating MALT lymphoma from follicular lymphoma and chronic gastritis.

H. Schouten, J. Arends, F. Bot, 1999, Histopathology.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

J. Klein, M. Horowitz, J. Wingard, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved survival after acute graft-versus-host disease diagnosis in the modern era

Alan M. Miller, R. Vij, W. Wood, 2017, Haematologica.

Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis.

E. Vellenga, J. Passweg, T. Pabst, 2015, The Lancet. Haematology.

Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMT

N. Schmitz, S. Montoto, P. Dreger, 2020, Bone Marrow Transplantation.

Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia.

H. Deeg, D. Porter, J. Cortes, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

Hamadani, M. Norkin, W. Wood, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diabetes mellitus or an impaired glucose tolerance as a potential complicating factor in patients treated with high-dose therapy and autologous bone marrow transplantation.

J. Armitage, J. Vose, H. Schouten, 1990, Bone Marrow Transplantation.

Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies.

E. V. van Pampus, K. Jie, A. Verbon, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Post-Transplant Cyclophosphamide (PT-Cy) for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Transplantation from HLA Identical Sibling and Matched Unrelated Donor for Patients with Acute Leukemia, on Behalf of ALWP-EBMT

N. Kröger, M. Labopin, D. Blaise, 2017 .

Pre-transplant marital status and hematopoietic cell transplantation outcomes.

W. Wood, K. Sullivan, M. Aljurf, 2020, Current oncology.

The involvement of Galectins in the modulation of the JAK/STAT pathway in myeloproliferative neoplasia.

H. Schouten, S. Koopmans, F. Bot, 2012, American journal of blood research.

Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report.

N. Kröger, P. Hari, D. Blaise, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).

Alan M. Miller, J. Armitage, J. Vose, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Working Parties

M. Labopin, P. Chevallier, A. Nagler, 2015, Bone Marrow Transplantation.

Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study

M. Aljurf, J. Szer, R. Gale, 2020 .

Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A

K. Rouschop, M. Tilanus, Yunping Xu, 2015, Cancer Immunology, Immunotherapy.

Pacritinib (PAC) vs best available therapy (BAT) in myelofibrosis (MF): 60 week follow-up of the phase III PERSIST-1 trial.

A. Mead, P. Ganly, R. Mesa, 2016 .

Pacritinib (PAC) vs best available therapy (BAT) in myelofibrosis (MF): Outcomes in patients (pts) with baseline (BL) thrombocytopenia

A. Mead, P. Ganly, R. Mesa, 2016 .

Body mass index, height, and risk of lymphatic malignancies: a prospective cohort study.

R. Goldbohm, P. A. van den Brandt, L. Schouten, 2009, American journal of epidemiology.

Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK‐NUP214 shows a favourable outcome when performed in first complete remission

J. Esteve, J. Sierra, M. Labopin, 2020, British journal of haematology.

Dietary Acrylamide Intake and the Risk of Lymphatic Malignancies: The Netherlands Cohort Study on Diet and Cancer

R. Goldbohm, P. A. van den Brandt, L. Schouten, 2012, PloS one.

Alcohol consumption and risk of lymphoid and myeloid neoplasms: Results of the Netherlands cohort study

R. Goldbohm, P. A. van den Brandt, L. Schouten, 2013, International journal of cancer.

The effect of smoking on allogeneic transplant outcomes.

K. Ballen, O. Ringdén, P. McCarthy, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Medication surveillance on intravenous cytotoxic agents: a retrospective study

Hugo de Wit, R. Janknegt, H. Schouten, 2013, International Journal of Clinical Pharmacy.

University of Groningen Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide Chamuleau,

M. Kersten, D. Jong, O. Hoekstra, 2020 .

Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter phase II HOVON trial

M. Kersten, D. de Jong, O. Hoekstra, 2019, Haematologica.

Comorbidity and treatment decision-making in elderly non-Hodgkin's lymphoma patients: a survey among haematologists.

W. J. Mulder, E. Maartense, H. Schouten, 2014, The Netherlands journal of medicine.

Identifying an accurate pre-screening tool in geriatric oncology.

F. Buntinx, E. Kellen, P. Bulens, 2010, Critical reviews in oncology/hematology.

Adherence to guidelines on nutrition support during intensive treatment of acute myeloid leukemia patients: A nationwide comparison.

S. Beijer, L. Tick, H. Schouten, 2020, Clinical nutrition ESPEN.

Dietary One-Carbon Nutrient Intake and Risk of Lymphoid and Myeloid Neoplasms: Results of the Netherlands Cohort Study

R. Goldbohm, P. A. van den Brandt, L. Schouten, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Clinical practices concerning central venous catheters in haematological patients.

H C Schouten, R S Boersma, H. Schouten, 2010, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

Quality of life after stem cell transplantation: a patient, partner and physician perspective.

H. Schouten, M. G. Hendriks, 2002, European journal of internal medicine.

Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Patient-reported Outcomes from the Phase II JAKARTA2 Trial

S. Verstovsek, R. Mesa, M. Talpaz, 2021, HemaSphere.

Randomized clinical trial of an intensive nursing-based pain education program for cancer outpatients suffering from pain

A. Courtens, M. van Kleef, J. Patijn, 2008, Supportive Care in Cancer.

Maintenance tyrosine kinase inhibitors following allo-HCT for chronic myeloid leukemia: A CIBMTR Study.

M. Aljurf, J. Szer, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Conventional therapeutic options have limited impact on MPN symptoms: Insights from a prospective analysis of the MPN-SAF TSS

T. Barbui, A. Dueck, R. Mesa, 2012 .

Fedratinib Induces Spleen Responses in Patients with Myeloproliferative Neoplasm (MPN)-Associated Intermediate- or High-Risk Myelofibrosis (MF) Resistant or Intolerant to Ruxolitinib: An Updated Analysis of the Phase II JAKARTA2 Study

S. Verstovsek, T. Gerike, R. Mesa, 2019, Clinical Lymphoma Myeloma and Leukemia.

Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation

M. Norkin, R. Vij, M. Horowitz, 2018, Bone Marrow Transplantation.

Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancer

S. Rodenhuis, M. Bontenbal, E. Vries, 2005, Breast Cancer Research and Treatment.

Cognitive functioning in survivors of hematopoietic stem cell transplantation compared with a matched general population sample - The MOSA study.

M. V. van Boxtel, C. Stehouwer, A. Wesselius, 2023, Transplantation and cellular therapy.

Selection bias in follow-up studies of stem cell transplantation survivors: an experience within the Maastricht Observational study of late effects after Stem cell trAnsplantation (MOSA)

S. Köhler, M. V. van Greevenbroek, H. Schouten, 2022, Annals of Hematology.

A288 Non-Myeloablative Allo-SCT for Relapsed Myeloma: A Single-Center Experience

M. Kersten, H. Lokhorst, M. Minnema, 2009 .

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy

J. Nortier, V. Tjan-Heijnen, E. Voest, 2011, Breast Cancer Research and Treatment.

Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma.

J. Coebergh, M. Janssen-Heijnen, D. V. van Spronsen, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Development and measurement of guideline-based indicators for patients with non-Hodgkin's lymphoma.

J. Raemaekers, C. Punt, R. Grol, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pneumonia due to Micrococcus spp. in a patient with acute myeloid leukaemia.

F. V. van Tiel, G. Blijham, H. Schouten, 1992, Leukemia.

Inappropriate costimulation and aberrant DNA methylation as therapeutic targets in angioimmunoblastic T-cell lymphoma

H. Schouten, M. Willemsen, 2017, Biomarker Research.

Course of mental fatigue and motivation in breast cancer patients receiving adjuvant chemotherapy.

A. Courtens, H. Abu‐Saad, M. Candel, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

The granularity of medical narratives and its effect on the speed and completeness of information retrieval.

Arie Hasman, Huibert J. Tange, Arnold D. M. Kester, 1998, Journal of the American Medical Informatics Association : JAMIA.

Blood: Principles and Practice of Hematology, 2nd edition

H. Schouten, 2004 .

NEURO/MEDICAL ONCOLOGY

Scott N. Hwang, Katrina H. Smith, Susan M. Chang, 2013 .

The prognostic value of a trend in modified SOFA score for patients with hematological malignancies in the intensive care unit

B. Winkens, W. V. van Mook, H. Schouten, 2017, European journal of haematology.

Symptom Burden As Primary Driver for Therapy in Patients with Myelofibrosis: An Analysis By MPN International Quality of Life Study Group

M. Griesshammer, T. Barbui, A. Dueck, 2016 .

ACUTE TUMOUR LYSIS SYNDROME IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER A SINGLE DOSE OF PREDNISONE

G. Blijham, H. Schouten, O. Loosveld, 1991, British journal of haematology.

Assessing long-term effects after stem cell transplantation: design of the MOSA study.

S. Köhler, M. V. van Greevenbroek, H. Schouten, 2022, Journal of clinical epidemiology.

Results of the PERSIST-1 phase III study of pacritinib (PAC) versus best available therapy (BAT) in primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF), or post-essential thrombocythemia-myelofibrosis (PET-MF).

A. Mead, P. Ganly, A. Vannucchi, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

General principles of treatment.

H. Schouten, HC Schouten, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Characterization of clonogenic cells in refractory anemia with excess of blasts (RAEB-CFU): response to recombinant hematopoietic growth factors and maturation phenotypes.

A. Hagemeijer, B. Löwenberg, I. Touw, 1989, Leukemia research.

Medical narratives in electronic medical records.

A Hasman, H J Tange, P F de Vries Robbé, 1997, International journal of medical informatics.

Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries

M. Dougados, S. van der Linden, F. Guillemin, 2002, Annals of the rheumatic diseases.

Invasive Aspergillus infections in patients with a malignancy: description of an outbreak and overview of the literature.

J. V. van Engelshoven, G. Blijham, H. Schouten, 1992, The Netherlands journal of medicine.

Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.

W Hop, H. V. D. Lelie, P. Sonneveld, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma.

J. Raemaekers, A. Hagenbeek, P. Sonneveld, 1995, The New England journal of medicine.

Low-input farming

H. Schouten, 1986 .

Incidence, survival and prevalence of myeloid malignancies in Europe.

C. Stiller, A. Trama, R. De Angelis, 2012, European journal of cancer.

Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries

M. Dougados, S. van der Linden, F. Guillemin, 2003, Annals of the rheumatic diseases.

The prognostic significance of steroid receptor activity in tumor tissues of patients with primary breast cancer.

J. Jager, L. Schouten, P. Hupperets, 1997, American journal of clinical oncology.

Prognostic and predictive factors in breast cancer.

H. Hillen, R. Jansen, H. Schouten, 1997, The Netherlands journal of medicine.

Gastric low-grade MALT lymphoma, high-grade MALT lymphoma and diffuse large B cell lymphoma show different frequencies of trisomy

J. Arends, E. Schuuring, J. Hermans, 1999, Leukemia.

Specific detection of Helicobacter pylori and non-Helicobacter pylori flora in small- and large-cell primary gastric B-cell non-Hodgkin's lymphoma.

J. Arends, D. Jonkers, L. Vrints, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.

M A Boogaerts, A. Hagenbeek, E. Vellenga, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Costs of ankylosing spondylitis in three European countries: the patient’s perspective

M. Dougados, S. van der Linden, F. Guillemin, 2003, Annals of the rheumatic diseases.

Fedratinib (FEDR) in myelofibrosis (MF) patients previously treated with ruxolitinib (RUX): A reanalysis of the JAKARTA-2 study.

S. Verstovsek, T. Gerike, R. Mesa, 2019, Journal of Clinical Oncology.

Effect of Rituximab in Primary Central Nervous System Lymphoma - results of the Randomized Phase III HOVON 105/ALLG NHL 24 Study

W. Stevens, J. Baars, D. Jong, 2017 .

Fibrinolysis in patients with chemotherapy‐induced thrombocytopenia and the effect of platelet transfusion

Y. Henskens, H. Schouten, P. Verhezen, 2019, Journal of thrombosis and haemostasis : JTH.

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.

J. Cortes, M. Aljurf, J. Szer, 2013, Blood.

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

J. Vose, Sonali M. Smith, P. Hari, 2012, Blood.

Course of the Fatigue Dimension "Activity Level" and the Interference of Fatigue With Daily Living Activities for Patients With Breast Cancer Receiving Adjuvant Chemotherapy

A. Courtens, H. Abu‐Saad, M. Candel, 2006, Cancer nursing.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

M. Horowitz, J. Wingard, R. Gale, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen.

S. Montoto, Sonali M. Smith, D. Maloney, 2015, Biology of Blood and Marrow Transplantation.

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.

U. Popat, M. Kalaycio, Z. DeFilipp, 2018, Blood advances.

Anorectal function: defecographic measurement in asymptomatic subjects.

J. V. Engelshoven, H. Schouten, R. Goei, 1989, Radiology.

Screening for platelet function disorders with Multiplate and platelet function analyzer

H. ten Cate, P. Nelemans, Y. Henskens, 2019, Platelets.

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.

M. Norkin, R. Vij, W. Wood, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.

A. Zander, J. Szer, M. Horowitz, 2008, Blood.

Identifying an accurate pre-screening tool in geriatric oncology.

F. Buntinx, E. Kellen, P. Bulens, 2010, Critical reviews in oncology/hematology.

Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants.

M. Norkin, H. Nakasone, M. Aljurf, 2018, Blood advances.

Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma.

J. Coebergh, M. Janssen-Heijnen, D. V. van Spronsen, 2012 .

Chronic Graft-Versus-Host Disease Risk Score: A CIBMTR Analysis

M. Horowitz, J. Wingard, R. Gale, 2010 .

Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs.

K. Döhner, M. Griesshammer, T. Barbui, 2017, Leukemia research.

Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group

K. Döhner, M. Griesshammer, T. Barbui, 2016, Haematologica.

Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.

M. Norkin, M. Perales, S. Mineishi, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.